Veterinary Medicines

Kelevo 400 µg tablets for dogs and cats

Authorised
  • Levothyroxine sodium
Download as PDF

Product identification

Medicine name:
Kelevo 400 µg tablets for dogs and cats
Kelevo 400 Mikrogramm Tabletten für Hunde und Katzen
Active substance:
  • Levothyroxine sodium
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Levothyroxine sodium
    400.00
    microgram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH03AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • PVC / PE / PVDC - Aluminium blister each with 25 tablets. Cardboard box with 50 tablets
  • PVC / PE / PVDC - Aluminium blister each with 25 tablets. Cardboard box with 250 tablets
  • PVC / PE / PVDC - Aluminium blister each with 25 tablets. Cardboard box with 100 tablets
  • PVC / PE / PVDC - Aluminium blister each with 10 tablets. Cardboard box with 50 tablets.
  • PVC / PE / PVDC - Aluminium blister each with 10 tablets. Cardboard box with 250 tablets
  • PVC / PE / PVDC - Aluminium blister each with 10 tablets. Cardboard box with 100 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Livisto Int'L S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • aniMedica GmbH
  • aniMedica Herstellungs GmbH
  • Industrial Veterinaria S.A.
  • Lelypharma B.V.
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 402764.00.00
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0349/002
Concerned member states:
  • Austria
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Portugal
  • Slovenia
  • Spain

Documents

Combined File of all Documents

English (PDF)
Published on: 20/03/2024
Download
German (PDF)
Published on: 20/12/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."